Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 7Lung Neoplasms 4Kidney Neoplasms 3Carcinoma, Renal Cell 3Breast Neoplasms 3Sarcoma 2Pain 2Melanoma 2Liver Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Biliary Tract Neoplasms 2Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Osteosarcoma 1Neoplasms 1Menorrhagia 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leiomyoma 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Neoplasms 1

Interventions

Ipilimumab 10tremelimumab 6durvalumab 5Nivolumab 3pembrolizumab 2tilsotolimod 1spartalizumab 1relatlimab 1folfirinox 1balstilimab 1Vemurafenib 1Vaccines 1Radiotherapy 1Radiofrequency Ablation 1Radiation 1Paclitaxel 1Oxaliplatin 1Opdualag 1Melphalan 1Leucovorin 1Fluorouracil 1Docetaxel 1Cryosurgery 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Diabetes Mellitus, Insulin-Dependent, 12 × Cryosurgery × Clear all
NCT02821754 2023-03-28

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
54 enrolled 14 charts
Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡